ANDIPAL AVEXIMA

Registration number:ЛСР-002455/08
Pharmaceutical form:tablets
Pharmacotherapeutic group:analgesic agent (nonnarcotic analgesic drug + spasmolytic agent + barbiturate)
Dosage form:tablets No. 10 and No. 20
Composition:active substances: metamizole sodium (analgin) - 250 mg, phenobarbital - 20 mg, bendazole (dibazole) - 20 mg, papaverine hydrochloride - 20 mg.

ANDIPAL AVEXIMA is a combination drug. Combination of the medicinal product ingredients results in mutual enhancement of their pharmacological effects.

Metamizole sodium produces analgesic and antipyretic effects.
Bendazole (dibazole) has a vasodilatory action. It has direct spasmolytic effects on smooth muscles of blood vessels and visceral organs.
Papaverine hydrochloride is a spasmolytic agent, which produces a hypotensive action, reduces tonicity, and relaxes the smooth muscles of visceral organs and vessels.
Phenobarbital at low doses has sedating effects and enhances the action of other components.

Indications for use:

pain syndrome (mild to moderate) associated with:
— peripheral artery spasm;
— gastrointestinal smooth muscles spasm;
—spasm of urogenital system;
— cerebral vessels spasm;
elevated blood pressure.

Method of administration and posology:

For oral administration. Duration of administration without doctor's prescription is not more than 7 days.